CYP19 (TTTA)n polymorphism and breast cancer risk in Brazilian women

Toxicology Letters

Volumn 164, Issue 1, 2006, Pages 90-95

  Ribeiro, Fabiana Siqueira ^a   de Amorim, Lídia Maria da Fonte ^b   de Almeida Simão, Tatiana ^a   Mendonça, Gulnar Azevedo ^a,c   de Moura Gallo, Cláudia Vitória ^a   Pinto, Luis Felipe Ribeiro ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^c INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

Brazil; Breast; Cancer; CYP19; Polymorphism

Indexed keywords

AROMATASE;

ADULT; AGED; ALLELE; ARTICLE; BRAZIL; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; NUCLEOTIDE REPEAT; PRIORITY JOURNAL; RISK ASSESSMENT; SOUTH AMERICA;

ADULT; AGED; AGED, 80 AND OVER; AROMATASE; BRAZIL; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICROSATELLITE REPEATS; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK;

EID: 33646111192     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2005.11.014     Document Type: Article

References (28)

1. Amorim L.M.F., Rossini A., Mendonça G.A.S., Lotsch P.F., Simão T.A., Gallo C.V.M., and Ribeiro Pinto L.F. CYP1A1, GSTM1, and GSTT1 polymorphisms and breast cancer risk in Brazilian women. Cancer Lett. 181 (2002) 179-186
2. Artamonov V.V., Lyubchenko L.N., Shabanov M.A., Babenko O.V., Nemtsova M.V., and Zaletaev D.V. The association of the CYP19 and CYP17 polymorphic markers with sporadic breast cancer. Mol. Biol. 37 (2003) 975-982
3. Baxter S.W., Choong D.Y., Eccles D.M., and Campbell I.G. Polymorphic variation in CYP19 and the risk of breast cancer. Carcinogenesis 22 (2001) 347-349
4. Brazilian Health Ministry, 2005. Estimativas da Incidência e Mortalidade por Câncer do Brasil, Instituto Nacional do Câncer (INCA), Ministério da Saúde, Brasil (www.inca.gov.br).
5. Carvalho-Silva D., Santos F.R., Rocha J., and Pena S.D. The phylogeography of Brazilian Y-chromosome lineages. Am. J. Hum. Genet. 68 (2001) 281-286
6. Colditz G.A. Epidemiology of breast cancer: findings from the nurses' health study. Cancer Suppl. 15 (1993) 1480-1489
7. Dialyna I., Tzanakakis G., Dolapsakis G., and Tsatsakis A. A tetranucleotide repeat polymorphism in the CYP19 gene and breast cancer susceptibility in a Greek population exposed and not exposed to pesticides. Toxicol. Lett. 151 (2004) 267-271
8. Dunning A.M., Healey C.S., Pharoah P.D., Teare M.D., Ponder B.A., and Easton D.F. A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol. Biomarkers Prev. 8 (1999) 843-854
9. Elston C.W., and Ellis I.O. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19 (1991) 403-410
10. Groover P.L., and Martin F.L. The initiation of breast and prostate cancer. Carcinogenesis 23 (2002) 1095-1102
11. Haiman C.A., Hankinson S.E., Spiegelman D., De Vivo J., Colditz G.A., Willett W.C., Speizer F.E., and Hunter D.J.A. A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk. Int. J. Cancer 87 (2000) 204-210
12. Healey C.S., Dunning A.M., Durocher F., Teare D., Pharoah P.D., Luben R.N., Easton D.F., and Ponder B.A. Polymorphisms in the human aromatase cytochrome P450 gene (CYP19) and breast cancer risk. Carcinogenesis 21 (2000) 189-193
13. Henderson B.E., and Feigelson H.S. Hormonal carcinogenesis. Carcinogenesis 21 (2000) 427-433
14. Kristensen V.N., Andersen T.L., Lindblom A., Nesland J., Olsen A., and Borresen-Dale A.L. A rare CYP19 (aromatase) variant may increase the risk of breast cancer. Pharmacogenetics 8 (1998) 43-48
15. Kristensen V.N., and Borresen-Dale A.L. Molecular epidemiology of breast cancer: genetic variation in steroid hormone metabolism. Mutat. Res. 462 (2000) 323-333
16. Lee J.S. Alternative dideoxy sequencing of double-stranded DNA by cyclic reactions using Taq polymerase. DNA Cell Biol. 10 (1991) 67-73
17. Mitrunen K., and Hirvonen A. Molecular epidemiology of sporadic breast cancer: the role of polymorphic genes involved in oestrogen biosynthesis and metabolism. Mutat. Res. 544 (2003) 9-41
18. McPherson K., Steel C.M., and Dixon J.M. ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics. BMJ 321 (2000) 624-628
19. Miyoshi Y., Ando A., Hasegawa S., Ishitobi M., Yamamura J., Irahara N., Tanji Y., Taguchi T., Tamaki Y., and Noguchi S. Association of genetic polymorphisms in CYP19 and CYP1A1 with the oestrogen receptor-positive breast cancer risk. Eur. J. Cancer 39 (2003) 2531-2537
20. Nandi S., Guzman R.C., and Yang J. Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis. Proc. Natl. Acad. Sci. 92 (1995) 3650-3657
21. Newman B., Austin M.A., and Lee M. Inheritance of human breast cancer: evidence of autosomal dominant transmission in high-risk families. Proc. Natl. Acad. Sci. 85 (1998) 3044-3048
22. Parkin D.M. Epidemiology of cancer: global patterns and trends. Toxicol. Lett. 102-103 (1998) 227-234
23. Probst-Hensch N.M., Ingles S.A., Diep A.T., Haile R.W., Stanczyk F.Z., Kolonel L.N., and Henderson B.E. Aromatase and breast cancer susceptibility. Endocr. Relat. Cancer 6 (1999) 165-173
24. Sanguinetti C.J., Neto E.D., and Simpson A.J.G. Rapid silver staining and recovery of PCR products separated on polyacrylamide gels. Biotechniques 17 (1994) 915-919
25. Siegelmann-Danieli N., and Buetow K.H. Constitutional genetic variation at the human aromatatase gene (CYP19) and breast cancer risk. Br. J. Cancer 79 (1999) 456-463
26. 7 allele in premenopausal versus postmenopausal breast cancer patients, but not in control individuals. Eur. J. Cancer 38 (2002) 1911-1916
27. Thyagarajan B., Brott M., Mink P., Folsom A.R., Anderson K.E., Oetting W.S., and Gross M. CYP1B1 and CYP19 gene polymorphisms and breast cancer incidence: no association in the ARIC study. Cancer Lett. 207 (2004) 183-189
28. Yager J.D. Endogenous estrogens as carcinogens through metabolic activation. J. Natl. Cancer Inst. Monogr. 27 (2000) 67-73